ConductScience.org, home

Trial · NCT02562066

Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Subject Global Impression (SGI) Score Summary: Mann-Whitney Main Effects Test Results; SGI Score Mixed Model AnalysisAmifampridine Phosphate - PlaceboStudy Period 1: CFB in SGI Score at Day 8-0.13Standard Deviation 1.81Scores on a scale
Subject Global Impression (SGI) Score Summary: Mann-Whitney Main Effects Test Results; SGI Score Mixed Model AnalysisPlacebo - Amifampridine PhosphateStudy Period 1: CFB in SGI Score at Day 8-1.75Standard Deviation 2.12Scores on a scale
Subject Global Impression (SGI) Score Summary: Mann-Whitney Main Effects Test Results; SGI Score Mixed Model AnalysisAmifampridine Phosphate - PlaceboStudy Period 2 : CFB in SGI Score at Day 29-0.75Standard Deviation 1.75Scores on a scale
Subject Global Impression (SGI) Score Summary: Mann-Whitney Main Effects Test Results; SGI Score Mixed Model AnalysisPlacebo - Amifampridine PhosphateStudy Period 2 : CFB in SGI Score at Day 29-1.14Standard Deviation 1.68Scores on a scale
Motor Function Measure 32 (MFM-32) Score Summary: Mann-Whitney Main Effect Test Results, MFM-32 Score Mixed Model AnalysisAmifampridine Phosphate - PlaceboStudy Period 1: CFB in Overall MFM-32 Score at Day 83.00Standard Deviation 3.92Score on a Scale
Motor Function Measure 32 (MFM-32) Score Summary: Mann-Whitney Main Effect Test Results, MFM-32 Score Mixed Model AnalysisPlacebo - Amifampridine PhosphateStudy Period 1: CFB in Overall MFM-32 Score at Day 8-0.17Standard Deviation 4.58Score on a Scale
Motor Function Measure 32 (MFM-32) Score Summary: Mann-Whitney Main Effect Test Results, MFM-32 Score Mixed Model AnalysisAmifampridine Phosphate - PlaceboStudy Period 2: CFB in Overall MFM-32 Score at Day 290.75Standard Deviation 2.22Score on a Scale
Motor Function Measure 32 (MFM-32) Score Summary: Mann-Whitney Main Effect Test Results, MFM-32 Score Mixed Model AnalysisPlacebo - Amifampridine PhosphateStudy Period 2: CFB in Overall MFM-32 Score at Day 29-0.60Standard Deviation 0.89Score on a Scale
Motor Function Measure 20 (MFM-20) Score Mixed Model Analysis, MFM-20 Score Mixed Model AnalysisAmifampridine Phosphate - PlaceboStudy Period 1: CFB in Overall MFM-20 Score at Day 8-1.50Standard Deviation 4.20Score on a Scale
Motor Function Measure 20 (MFM-20) Score Mixed Model Analysis, MFM-20 Score Mixed Model AnalysisPlacebo - Amifampridine PhosphateStudy Period 1: CFB in Overall MFM-20 Score at Day 8-0.50Standard Deviation 6.36Score on a Scale
Motor Function Measure 20 (MFM-20) Score Mixed Model Analysis, MFM-20 Score Mixed Model AnalysisAmifampridine Phosphate - PlaceboStudy Period 2: CFB in Overall MFM-20 Score at Day 29-0.75Standard Deviation 0.50Score on a Scale
Motor Function Measure 20 (MFM-20) Score Mixed Model Analysis, MFM-20 Score Mixed Model AnalysisPlacebo - Amifampridine PhosphateStudy Period 2: CFB in Overall MFM-20 Score at Day 291.50Standard Deviation 2.12Score on a Scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02562066/results